Accounting for Medicaid expansion and regional policy and programs to advance equity in cancer prevention in the United States

IF 6.1 2区 医学 Q1 ONCOLOGY Cancer Pub Date : 2023-07-25 DOI:10.1002/cncr.34956
Kirsten Y. Eom PhD, MPH, Siran M. Koroukian PhD, Weichuan Dong PhD, Uriel Kim PhD, Johnie Rose MD, PhD, Jeffrey M. Albert PhD, Kristine M. Zanotti MD, Cynthia Owusu MD, Gregory Cooper MD, Jennifer Tsui PhD, MPH
{"title":"Accounting for Medicaid expansion and regional policy and programs to advance equity in cancer prevention in the United States","authors":"Kirsten Y. Eom PhD, MPH,&nbsp;Siran M. Koroukian PhD,&nbsp;Weichuan Dong PhD,&nbsp;Uriel Kim PhD,&nbsp;Johnie Rose MD, PhD,&nbsp;Jeffrey M. Albert PhD,&nbsp;Kristine M. Zanotti MD,&nbsp;Cynthia Owusu MD,&nbsp;Gregory Cooper MD,&nbsp;Jennifer Tsui PhD, MPH","doi":"10.1002/cncr.34956","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Many studies compare state-level outcomes to estimate changes attributable to Medicaid expansion. However, it is imperative to conduct more granular, demographic-level analyses to inform current efforts on cancer prevention among low-income adults. Therefore, the authors compared the volume of patients with cancer and disease stage at diagnosis in Ohio, which expanded its Medicaid coverage in 2014, with those in Georgia, a nonexpansion state, by cancer site and health insurance status.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>The authors used state cancer registries from 2010 to 2017 to identify adults younger than 64 years who had incident female breast cancer, cervical cancer, or colorectal cancer. Multivariable Poisson regression was conducted by cancer type, health insurance, and state to examine the risk of late-stage disease, adjusting for individual-level and area-level covariates. A difference-in-differences framework was then used to estimate the differences in risks of late-stage diagnosis in Ohio versus Georgia.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>In Ohio, the largest increase in all three cancer types was observed in the Medicaid group after Medicaid expansion. In addition, significantly reduced risks of late-stage disease were observed among patients with breast cancer on Medicaid in Ohio by approximately 7% and among patients with colorectal cancer on Medicaid in Ohio and Georgia after expansion by approximately 6%. Notably, the authors observed significantly reduced risks of late-stage diagnosis among all patients with colorectal cancer in Georgia after expansion.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>More early stage cancers in the Medicaid-insured and/or uninsured groups after expansion suggest that the reduced cancer burden in these vulnerable population subgroups may be attributed to Medicaid expansion. Heterogeneous risks of late-stage disease by cancer type highlight the need for comprehensive evaluation frameworks, including local cancer prevention efforts and federal health policy reforms.</p>\n </section>\n \n <section>\n \n <h3> Plain Language Summary</h3>\n \n <div>\n \n <ul>\n \n <li>\n \n <p>This study looked at how Medicaid expansion affected cancer diagnosis and treatment in two states, Ohio and Georgia.</p>\n </li>\n \n <li>\n \n <p>The researchers found that, after Ohio expanded their Medicaid program, there were more patients with cancer among low-income adults on Medicaid.</p>\n </li>\n \n <li>\n \n <p>The study also found that, among people on Medicaid, there were lower rates of advanced cancer at the time of diagnosis for breast cancer and colon cancer in Ohio and for colon cancer in Georgia.</p>\n </li>\n \n <li>\n \n <p>These findings suggest that Medicaid expansion may be effective in reducing the cancer burden among low-income adults.</p>\n </li>\n </ul>\n </div>\n </section>\n </div>","PeriodicalId":138,"journal":{"name":"Cancer","volume":"129 24","pages":"3915-3927"},"PeriodicalIF":6.1000,"publicationDate":"2023-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cncr.34956","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Many studies compare state-level outcomes to estimate changes attributable to Medicaid expansion. However, it is imperative to conduct more granular, demographic-level analyses to inform current efforts on cancer prevention among low-income adults. Therefore, the authors compared the volume of patients with cancer and disease stage at diagnosis in Ohio, which expanded its Medicaid coverage in 2014, with those in Georgia, a nonexpansion state, by cancer site and health insurance status.

Methods

The authors used state cancer registries from 2010 to 2017 to identify adults younger than 64 years who had incident female breast cancer, cervical cancer, or colorectal cancer. Multivariable Poisson regression was conducted by cancer type, health insurance, and state to examine the risk of late-stage disease, adjusting for individual-level and area-level covariates. A difference-in-differences framework was then used to estimate the differences in risks of late-stage diagnosis in Ohio versus Georgia.

Results

In Ohio, the largest increase in all three cancer types was observed in the Medicaid group after Medicaid expansion. In addition, significantly reduced risks of late-stage disease were observed among patients with breast cancer on Medicaid in Ohio by approximately 7% and among patients with colorectal cancer on Medicaid in Ohio and Georgia after expansion by approximately 6%. Notably, the authors observed significantly reduced risks of late-stage diagnosis among all patients with colorectal cancer in Georgia after expansion.

Conclusions

More early stage cancers in the Medicaid-insured and/or uninsured groups after expansion suggest that the reduced cancer burden in these vulnerable population subgroups may be attributed to Medicaid expansion. Heterogeneous risks of late-stage disease by cancer type highlight the need for comprehensive evaluation frameworks, including local cancer prevention efforts and federal health policy reforms.

Plain Language Summary

  • This study looked at how Medicaid expansion affected cancer diagnosis and treatment in two states, Ohio and Georgia.

  • The researchers found that, after Ohio expanded their Medicaid program, there were more patients with cancer among low-income adults on Medicaid.

  • The study also found that, among people on Medicaid, there were lower rates of advanced cancer at the time of diagnosis for breast cancer and colon cancer in Ohio and for colon cancer in Georgia.

  • These findings suggest that Medicaid expansion may be effective in reducing the cancer burden among low-income adults.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
核算医疗补助扩展和地区政策及计划,以促进美国癌症预防的公平性
背景:许多研究比较了州一级的结果,以估计医疗补助扩张带来的变化。然而,必须进行更细致的人口层面的分析,以便为目前在低收入成年人中预防癌症的努力提供信息。因此,作者将2014年扩大医疗补助覆盖范围的俄亥俄州与未扩大医疗补助覆盖范围的佐治亚州的癌症患者数量和疾病诊断阶段进行了比较,对比了癌症部位和健康保险状况。方法:作者使用2010年至2017年的国家癌症登记处来确定64岁以下发生女性乳腺癌、宫颈癌或结直肠癌的成年人。根据癌症类型、健康保险和州进行多变量泊松回归,以检查晚期疾病的风险,并调整个体水平和区域水平的协变量。然后使用差异中的差异框架来估计俄亥俄州与佐治亚州晚期诊断风险的差异。结果在俄亥俄州,在医疗补助扩大后,在医疗补助组观察到所有三种癌症类型的最大增长。此外,在俄亥俄州接受医疗补助的乳腺癌患者中,晚期疾病的风险显著降低了约7%,在俄亥俄州和佐治亚州接受医疗补助的结直肠癌患者中,扩大后的风险显著降低了约6%。值得注意的是,作者观察到格鲁吉亚所有结直肠癌患者在扩大后的晚期诊断风险显著降低。结论医疗补助扩大后,参保人群和/或未参保人群的早期癌症发生率增加,表明这些弱势人群的癌症负担减轻可能归因于医疗补助扩大。按癌症类型划分的晚期疾病的异质性风险突出表明需要建立综合评估框架,包括地方癌症预防工作和联邦卫生政策改革。这项研究着眼于医疗补助计划的扩大如何影响俄亥俄州和佐治亚州两个州的癌症诊断和治疗。研究人员发现,在俄亥俄州扩大了他们的医疗补助计划之后,医疗补助计划的低收入成年人中有更多的癌症患者。研究还发现,在接受医疗补助的人群中,在俄亥俄州和佐治亚州被诊断为乳腺癌和结肠癌时,晚期癌症的发病率较低。这些发现表明,扩大医疗补助可能有效地减轻低收入成年人的癌症负担。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cancer
Cancer 医学-肿瘤学
CiteScore
13.10
自引率
3.20%
发文量
480
审稿时长
2-3 weeks
期刊介绍: The CANCER site is a full-text, electronic implementation of CANCER, an Interdisciplinary International Journal of the American Cancer Society, and CANCER CYTOPATHOLOGY, a Journal of the American Cancer Society. CANCER publishes interdisciplinary oncologic information according to, but not limited to, the following disease sites and disciplines: blood/bone marrow; breast disease; endocrine disorders; epidemiology; gastrointestinal tract; genitourinary disease; gynecologic oncology; head and neck disease; hepatobiliary tract; integrated medicine; lung disease; medical oncology; neuro-oncology; pathology radiation oncology; translational research
期刊最新文献
A systematic review and meta-analysis of patient-relevant outcomes in comprehensive cancer centers versus noncomprehensive cancer centers. American Society of Clinical Oncology guideline update on palliative care for patients with cancer: Addressing the reality gap. Embrace with caution: The limitations of generative artificial intelligence in responding to patient health care queries. Expression of Concern. Global disparities in cancer care: Bridging the gap in affordability and access to medications between high and low-income countries.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1